Abbott Loses Bid For Judgment In $200M Stent Case

Law360, New York (May 18, 2009, 12:00 AM EDT) -- A judge has shot down Abbott Laboratories' bid for summary judgment on Medtronic Inc.'s claims for lost profits, in a suit alleging infringement of stent patents and seeking more than $200 million in lost profits, damages and interest.

On Friday, Judge Phyllis J. Hamilton of the U.S. District Court for the Northern District of California issued a mixed ruling on cross motions for summary judgment, finding that most of Abbott's arguments were in dispute.

The motions for summary judgment relate to Medtronic's claim for lost profits...
To view the full article, register now.